CN113583946B - 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型 - Google Patents

三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型 Download PDF

Info

Publication number
CN113583946B
CN113583946B CN202110909867.9A CN202110909867A CN113583946B CN 113583946 B CN113583946 B CN 113583946B CN 202110909867 A CN202110909867 A CN 202110909867A CN 113583946 B CN113583946 B CN 113583946B
Authority
CN
China
Prior art keywords
fibroblasts
fibroblast
dimensional
cell
aggregate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110909867.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN113583946A (zh
Inventor
金相宪
崔淙勋
朴贵德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Yonsei University
Original Assignee
Industry Academic Cooperation Foundation of Yonsei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Yonsei University filed Critical Industry Academic Cooperation Foundation of Yonsei University
Priority to CN202110909867.9A priority Critical patent/CN113583946B/zh
Publication of CN113583946A publication Critical patent/CN113583946A/zh
Application granted granted Critical
Publication of CN113583946B publication Critical patent/CN113583946B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
CN202110909867.9A 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型 Active CN113583946B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110909867.9A CN113583946B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1020150159011A KR20170055791A (ko) 2015-11-12 2015-11-12 인 비트로 3ｄ 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법
KR10-2015-0159011 2015-11-12
CN202110909867.9A CN113583946B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型
PCT/KR2016/004043 WO2017082491A1 (ko) 2015-11-12 2016-04-19 3차원 섬유아세포집합체 및 그를 포함하는 인 비트로 3d 피부 진피 모델
CN201680003627.XA CN107002032B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680003627.XA Division CN107002032B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型

Publications (2)

Publication Number Publication Date
CN113583946A CN113583946A (zh) 2021-11-02
CN113583946B true CN113583946B (zh) 2024-11-08

Family

ID=58695687

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202110909867.9A Active CN113583946B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型
CN201680003627.XA Active CN107002032B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680003627.XA Active CN107002032B (zh) 2015-11-12 2016-04-19 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型

Country Status (6)

Country Link
US (1) US10725043B2 (https=)
EP (1) EP3375865A4 (https=)
JP (4) JP6933378B2 (https=)
KR (1) KR20170055791A (https=)
CN (2) CN113583946B (https=)
WO (1) WO2017082491A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170055791A (ko) * 2015-11-12 2017-05-22 한국과학기술연구원 인 비트로 3ｄ 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법
KR102213922B1 (ko) * 2017-06-30 2021-02-08 (주)아모레퍼시픽 인공피부 제조방법 및 인공피부
EP3708653A4 (en) * 2017-11-10 2021-08-18 Toppan Printing Co., Ltd. ARTIFICIAL ADAPTIVE TISSUE AND METHOD FOR MANUFACTURING THEREOF, METHOD FOR MANUFACTURING ARTIFICIAL SKIN AND AGENTS FOR FAT CELLS
CN108795867A (zh) * 2018-06-05 2018-11-13 华东理工大学 用于构建结肠癌细胞腹膜转移体外三维模型的方法
WO2022024886A1 (ja) * 2020-07-27 2022-02-03 株式会社コーセー 全分泌調節剤の評価及び／又は選択方法
KR102365125B1 (ko) * 2020-08-12 2022-02-18 주식회사 티앤알바이오팹 인공 피부 모델을 사용한 피부 탄성 측정 방법 및 피부 첨가제의 스크리닝 혹은 선별 방법
CN114107429A (zh) * 2021-12-02 2022-03-01 云南贝泰妮生物科技集团股份有限公司 一种化妆品原料体外3d皮肤模型屏障修复功效的筛选方法
CN114292894B (zh) * 2022-01-14 2023-08-11 广东悠质检测技术有限公司 一种用体外细胞评价化妆品及原料紧致功效的方法
CN119286771A (zh) * 2024-10-28 2025-01-10 深圳锦时生物科技有限公司 一种高效分离自体皮肤来源的成纤维细胞培养方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03266980A (ja) 1989-03-16 1991-11-27 W R Grace & Co 細胞培養用基材およびそれを用いた細胞集合体の製造方法
JPH0489000A (ja) * 1990-05-02 1992-03-23 W R Grace & Co 細胞培養キットおよび細胞傷害試験法
JP4751005B2 (ja) * 2000-05-31 2011-08-17 フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー．ファオ． 三次元皮膚モデル
JP3709369B2 (ja) 2001-11-13 2005-10-26 丸善製薬株式会社 皮膚化粧料及び美容用飲食品
DE102004039537A1 (de) * 2004-08-13 2006-02-23 Phenion Gmbh & Co. Kg Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes
JP4792566B2 (ja) 2005-06-01 2011-10-12 財団法人ヒューマンサイエンス振興財団 樹状細胞を含む三次元培養ヒト皮膚モデル
JP2010172240A (ja) * 2009-01-28 2010-08-12 Shiseido Co Ltd エラスチン発現低下を回復する薬剤のスクリーニング方法
JP2010193822A (ja) 2009-02-26 2010-09-09 Toyobo Co Ltd ３次元培養細胞により作成した皮膚同等物およびそれを用いる紫外線の影響の評価方法
KR101094445B1 (ko) 2009-05-13 2011-12-15 한국과학기술연구원 줄기세포에 대한 접착활성을 갖는 섬유아세포 성장인자의 재조합 단백질 및 이를 이용한 줄기세포의 배양방법
JP2012050406A (ja) 2010-09-03 2012-03-15 Genesis Healthcare Kk 皮膚関連遺伝子の検出方法、並びに該遺伝子を用いた肌情報の提供方法、化粧品の販売システム、化粧品の販売方法及び化粧品成分のスクリーニング方法
CN104263698B (zh) * 2014-09-19 2016-05-18 江苏华亿细胞组织工程有限公司 临床治疗级细胞治疗用成纤维细胞规模化制备人类细胞外基质筛选培养方法
KR20170055791A (ko) 2015-11-12 2017-05-22 한국과학기술연구원 인 비트로 3ｄ 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Park IS等.A novel three-dimensional adipose-derived stem cell cluster for vascular regeneration in ischemic tissue.CYTOTHERAPY.2014,第16卷(第4期),第509页左栏最后1段、第510页右栏最后1段，第514页左栏第1段第1-3行，右栏最后1段-第515页左栏第1段，第519页左栏最后1段. *
Sangmyung Rhee等.Promigratory and Procontractile Growth Factor Environments Differentially Regulate Cell Morphogenesis.Exp Cell Res.2010,第316卷(第2期),摘要，第233页左栏第1段，右栏第2段，第234页左栏第1段，第239页左栏第2段. *

Also Published As

Publication number Publication date
JP2024133695A (ja) 2024-10-02
CN107002032B (zh) 2021-08-27
CN107002032A (zh) 2017-08-01
JP7525939B2 (ja) 2024-07-31
JP7727339B2 (ja) 2025-08-21
JP2023058684A (ja) 2023-04-25
US10725043B2 (en) 2020-07-28
US20180252715A1 (en) 2018-09-06
JP2018535646A (ja) 2018-12-06
JP7235350B2 (ja) 2023-03-08
EP3375865A1 (en) 2018-09-19
WO2017082491A1 (ko) 2017-05-18
JP6933378B2 (ja) 2021-09-08
EP3375865A4 (en) 2019-07-10
JP2021180681A (ja) 2021-11-25
CN113583946A (zh) 2021-11-02
KR20170055791A (ko) 2017-05-22

Similar Documents

Publication Publication Date Title
CN113583946B (zh) 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型
Zhu et al. Decellularized extracellular matrix for remodeling bioengineering organoid's microenvironment
Prestwich Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery
US9644183B2 (en) Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
Gupta et al. Surface patterning and innate physicochemical attributes of silk films concomitantly govern vascular cell dynamics
Lyu et al. Graphene hydrogel as a porous scaffold for cartilage regeneration
LaNasa et al. Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering
Zhu et al. Cell–cell interactions enhance cartilage zonal development in 3D gradient hydrogels
Huang et al. Engineering a self-assembling leucine zipper hydrogel system with function-specific motifs for tissue regeneration
Ravikrishnan et al. Hydrogel-supported, engineered model of vocal fold epithelium
Scott et al. Three-dimensional cell entrapment as a function of the weight percent of peptide-amphiphile hydrogels
KR101919930B1 (ko) 인 비트로 3차원 세포 배양 모델, 이의 제조 방법 및 이를 이용한 스크리닝 방법
WO2010110596A2 (en) Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
Metkari et al. Matrix degradability contributes to the development of salivary gland progenitor cells with secretory functions
HK40056234A (en) Three-dimensional fibroblast aggregate and in vitro 3d skin dermis model comprising same
KR102066670B1 (ko) 인 비트로 3ｄ 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법
HK40056234B (zh) 三维成纤维细胞集合体及包含此的体外三维皮肤真皮模型
KR102261934B1 (ko) Mbp-fgf2를 이용한 3차원 섬유아세포집합체를 제조하는 방법
KR102236977B1 (ko) 3차원 섬유아세포집합체 및 그의 생산방법
KR20170132121A (ko) 인 비트로 3ｄ 피부 진피 모델 및 그를 사용하여 약물을 스크리닝하는 방법
KR20200126478A (ko) 혈청유래 단백질을 포함하는 다공성 세포지지체 및 제조방법
Sari et al. Targeting Mechanobiology of Stem Cells Via Biomaterials for Regenerative Medicine Approaches
Ghosh et al. Cell-Material Interaction in Sustainable Biomedical Engineering
Mabry The Role of Matrix Properties in Directing Valvular Interstitial Cell Phenotype
Wang Signaling from matrix elasticity and TGF-β1 to cells of the cardiac valve

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40056234

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant